Personalized prediction for a 89 year old man who takes Edarbyclor (an AI-powered real world drug study)

Summary:

This is a personalized prediction of potential side effects and undetected conditions for up to one year, if you would have adverse effects. The study is created by eHealthMe based on data from the FDA.

What are the drugs?

Edarbyclor has active ingredients of azilsartan kamedoxomil; chlorthalidone. It is often used in high blood pressure. eHealthMe is studying from 1,412 Edarbyclor users. Check the latest studies of Edarbyclor.

What are the conditions?

Blood pressure - high is found to be associated with 4,796 drugs and 5,344 conditions by eHealthMe. Check the latest studies of Blood pressure - high.

Potential side effects:

Death

12.35% for males aged 89 (±5) who take edarbyclor

Fall

6.91% for males aged 89 (±5) who have blood pressure - high

Hypotension

6.26% for males aged 89 (±5) who have blood pressure - high

Potential co-existing conditions:

Atrial fibrillation/flutter

15.71% for males aged 89 (±5) who have blood pressure - high
6.3% for males aged 89 (±5) who take edarbyclor

Constipation

5.96% for males aged 89 (±5) who have blood pressure - high

Diabetes

8.51% for males aged 89 (±5) who have blood pressure - high

Enlarged prostate

9.71% for males aged 89 (±5) who have blood pressure - high

Gastroesophageal reflux disease

6.57% for males aged 89 (±5) who have blood pressure - high

High blood cholesterol

12.72% for males aged 89 (±5) who have blood pressure - high

Pain

6.65% for males aged 89 (±5) who have blood pressure - high

Prostate cancer

6.56% for males aged 89 (±5) who take edarbyclor

Type 2 diabetes

5.88% for males aged 89 (±5) who have blood pressure - high

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used, and more. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.